BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33472068)

  • 21. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
    Zhang B; Laribee RN; Klemsz MJ; Roman A
    Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
    Shiota H; Alekseyenko AA; Wang ZA; Filic I; Knox TM; Luong NM; Huang Y; Scott DA; Jones KL; Gokhale PC; Lemieux ME; Cole PA; Kuroda MI; French CA
    Mol Cancer Res; 2021 Nov; 19(11):1818-1830. PubMed ID: 34285087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells.
    Patzlaff JS; Terrenoire E; Turner BM; Earnshaw WC; Paulson JR
    Exp Cell Res; 2010 Aug; 316(13):2123-35. PubMed ID: 20452346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the Expression and Role of Histone Acetylation and Deacetylation in Dental Pulp Cells.
    Yamauchi Y; Duncan HF
    Methods Mol Biol; 2023; 2588():279-293. PubMed ID: 36418694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin.
    Devaiah BN; Case-Borden C; Gegonne A; Hsu CH; Chen Q; Meerzaman D; Dey A; Ozato K; Singer DS
    Nat Struct Mol Biol; 2016 Jun; 23(6):540-8. PubMed ID: 27159561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation.
    Hesping E; Skinner-Adams TS; Fisher GM; Kurz T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():249-256. PubMed ID: 33279862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.
    Chen S; Bellew C; Yao X; Stefkova J; Dipp S; Saifudeen Z; Bachvarov D; El-Dahr SS
    J Biol Chem; 2011 Sep; 286(37):32775-89. PubMed ID: 21778236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of histone deacetylases in embryonic development.
    Dsilva P; Pai P; Shetty MG; Babitha KS
    Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.
    Stratton MS; McKinsey TA
    Biochem Cell Biol; 2015 Apr; 93(2):149-57. PubMed ID: 25707943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
    Schuetze KB; McKinsey TA; Long CS
    J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitor.
    Zhao Y; Fang X; Wang Y; Zhang J; Jiang S; Liu Z; Ma Z; Xu L; Li E; Zhang K
    Curr Pharm Des; 2014; 20(11):1866-73. PubMed ID: 23888955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke.
    Xu Y; Wang Q; Chen J; Ma Y; Liu X
    Dis Markers; 2020; 2020():8820803. PubMed ID: 32963637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S; Archer TK
    Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma.
    Collier CD; Getty PJ; Greenfield EM
    Adv Exp Med Biol; 2020; 1258():55-75. PubMed ID: 32767234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histone modification and its application in therapy for hematologic malignancies -- review].
    Fang MH; Ji XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):816-20. PubMed ID: 19549415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
    Richon VM
    Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver.
    Yamada A; Honma K; Mochizuki K; Goda T
    Metabolism; 2016 Oct; 65(10):1478-88. PubMed ID: 27621183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Thieno[2,3-
    Pan Z; Li X; Wang Y; Jiang Q; Jiang L; Zhang M; Zhang N; Wu F; Liu B; He G
    J Med Chem; 2020 Apr; 63(7):3678-3700. PubMed ID: 32153186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.